Moexipril hydrochloride, 98%, 25mg

N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide, 97%, 25g

(2E)-3-(2,3-dimethoxyphenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(4-((TERT-BUTOXYCARBONYL)AMINO)-2-FLUOROPHENYL)BORONIC ACID, 95.0%, 5g

3-(3-(Trifluoromethyl)phenyl)propanenitrile, 97%, 1g

tert-Butyl 7-hydroxy-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-5(6H)-carboxylate, 95%, 250mg

Dibenzo[b,d]furan-4,6-diyldiboronic acid, 97%, 1g

3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)propanoic acid, 95.0%, 100mg

4-Hydroxyquinazoline>98.0%(T)5g

DIMETHYL 3-((TERT-BUTOXYCARBONYL)AMINO)PENTANEDIOATE, 95.0%, 250mg

2-Cyclohexyloxy-phenylamine hydrochloride, 1g

Object glass holder accessories ROTILABO® 1 piece

(R)-5-Benzyl-2-mesityl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate, 97%, 1g